Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa L Vincent

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|February 19, 2024
Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T CellsRosa L Vincent, Fangda Li, Edward R Ballister, et al.
Nature Biotechnology|April 1, 2025
The emerging landscape of engineered bacteria cancer therapiesEdward R Ballister, Alexander Michels, Rosa L Vincent, et al.
Science Immunology|October 18, 2024
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanismsFangda Li, Zaofeng Yang, Thomas M Savage, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapyMathieu Rouanne, Noah Chen, Dylan L Mariuzza, et al.
Science Advances|March 8, 2023
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunityThomas M Savage, Rosa L Vincent, Sarah S Rae, et al.
Science (New York, N.Y.)|October 12, 2023
Probiotic-guided CAR-T cells for solid tumor targetingRosa L Vincent, Candice R Gurbatri, Fangda Li, et al.
Nature|October 16, 2024
Probiotic neoantigen delivery vectors for precision cancer immunotherapyAndrew Redenti, Jongwon Im, Benjamin Redenti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|February 19, 2024
Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T CellsRosa L Vincent, Fangda Li, Edward R Ballister, et al.
Nature Biotechnology|April 1, 2025
The emerging landscape of engineered bacteria cancer therapiesEdward R Ballister, Alexander Michels, Rosa L Vincent, et al.
Science Immunology|October 18, 2024
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanismsFangda Li, Zaofeng Yang, Thomas M Savage, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapyMathieu Rouanne, Noah Chen, Dylan L Mariuzza, et al.
Science Advances|March 8, 2023
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunityThomas M Savage, Rosa L Vincent, Sarah S Rae, et al.
Science (New York, N.Y.)|October 12, 2023
Probiotic-guided CAR-T cells for solid tumor targetingRosa L Vincent, Candice R Gurbatri, Fangda Li, et al.
Nature|October 16, 2024
Probiotic neoantigen delivery vectors for precision cancer immunotherapyAndrew Redenti, Jongwon Im, Benjamin Redenti, et al.
Pageof 1